Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Braze, Inc. (BRZE) Prices 8M Share IPO at $65/sh
-
Iris Energy Limited Announces Pricing of Initial Public Offering
-
Iris Energy Limited Announces Pricing of Initial Public Offering
-
Braze Announces Pricing of Initial Public Offering
-
UserTesting Announces Pricing of Initial Public Offering
-
The Power Play by The Market Herald Releases New Interviews with Nextech AR, i-80 Gold, Kidoz Inc., Rakovina Therapeutics, Prophecy DeFi, and Saturn Oil & Gas Discussing Their Latest Press Releases
-
Privia Health Group, Inc (PRVA) Announces 6M Share Secondary Offering
-
Privia Health Announces Secondary Offering
-
Rover Group (ROVR) Launches 11M Share Secondary Offering
-
Rover Group (ROVR) to Offer 11M Shares
-
Rover Announces Launch of Secondary Offering
-
Rover Announces Launch of Secondary Offering
-
AVITA Medical to Present at Upcoming Investor Conferences
-
Tokens.com Announces Closing Of $16 Million Private Placement
-
Woodbridge Ventures II Inc. Announces Listing on the TSX Venture Exchange, Closing of Initial Public Offering, and Trading on the TSX Venture Exchange
-
Rocket Lab USA (RKLB) PT Lowered to $28 at Canaccord Genuity to Include Additional Warrants
-
PLBY Group, Inc. (PLBY) PT Lowered to $47 at Canaccord Genuity on Supply Chain Disruptions
-
Arizona Sonoran Announces Closing of Initial Public Offering
-
EverCommerce (EVCM) Launches 11M Share Offering
-
Atalaya Mining PLC Announces Exchange Rate of Inaugural Dividend
-
EverCommerce Announces Launch of Follow-On Offering
-
EverCommerce Announces Launch of Follow-On Offering
-
Clover Health (CLOV) Stock Dinged 9% on 35M Share Stock Offering
-
Definitive Healthcare (DH) Announces Launch of Proposed Follow-On Offering of 11M Shares of Class A Common Stock
-
Definitive Healthcare Announces Launch of Proposed Follow-On Offering of 11,000,000 Shares of Class A Common Stock
-
Definitive Healthcare Announces Launch of Proposed Follow-On Offering of 11,000,000 Shares of Class A Common Stock
-
CytoSorbents to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum and Jefferies London Healthcare Conference
-
KnowBe4 Announces Closing of Follow-On Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
-
KnowBe4 Announces Closing of Follow-On Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
-
Clover Health Investments (CLOV) Announces 35M Share Proposed Public Offering of Class A Common Stock
-
Clover Health Investments, Corp. Announces Proposed Public Offering of Class A Common Stock
-
Stewart Information Services (STC) Files For US IPO
-
Sangoma Announces Initial Public Offering in the United States
-
Sangoma Announces Initial Public Offering in the United States
-
Aziyo Biologics to Participate in Upcoming Virtual Investor Conferences
-
Oneview Healthcare PLC Successfully Completes A$20 Million Placement to Institutional Investors
-
System1 to Participate in Upcoming Investor Events
-
T2 Biosystems to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
-
Plant-Based Food & Beverage Company Led by All Women C-Suite and Board Completes IPO and Will Commence Trading on the TSX-V Under the Ticker Symbol "MYLK"
-
Jack Nathan Health to Present at Canaccord Genuity Health and Wellness Conference
-
Canaccord Genuity G Ventures Corp. Reports Third Quarter 2021 Financial Results
-
Givex Corporation and County Capital 2 Ltd. Announce Closing of Upsized $22 Million Private Placement and Uplisting to The Toronto Stock Exchange in Connection with Qualifying Transaction
-
Mynaric AG (MYNA) Prices 4M ADS IPO at $16.50/ADS
-
Mynaric has Announced Pricing of Initial Public Offering in the United States
-
Bioceres Crop Solutions to Participate in Upcoming Investor Conferences
-
Mynaric AG (MYNA) IPO Opens Higher
-
CalAmp Corp. (CAMP) PT Lowered to $15 at Canaccord Genuity
-
NervGen Pharma Completes $9.2 Million Bought Deal Financing
-
VSE Corporation (VSEC) PT Raised to $72 at Canaccord Genuity on Continued Strong Bizjet Flight Volume
-
Quanterix to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum

